Skip to main content
. 2020 May 26;15(5):e0232533. doi: 10.1371/journal.pone.0232533

Table 2. Characteristics of doctor shopping patients during doctor shopping and non-doctor shopping periods (mean, median [IQR] unless otherwise indicated).

When Doctor Shopping When not Doctor Shopping
Patients, N (%) 37,333 33,762*
Time data
    Active time (days) 395 288 [228, 437] 907 729 [307, 1390]
Prescription data
    Prescriptions/patient 26.2 16 [10, 28] 36.2 21 [7, 53]
    Prescriptions/patient/month 1.8 1.6 [1.2, 2.2] 1.0 .9 [.6, 1.3]
    MME/prescription (patient weighted) 837 487 [251, 929] 1067 552 [252, 1142]
Prescriber data
    Prescribers/patient 10.4 7 [6, 11] 6.9 6 [3, 10]
    Prescribers/patient/month .83 .80 [.69, .92] .30 .28 [.18, .37]
    Prescriptions/provider (patient weighted) 2.3 1.9 [1.4, 2.8] 5.0 3.3 [1.7, 6.4]
Usage data
    Total morphine equivalents/patient 27312 8425 [3260, 23330] 56260 12089 [2350, 48028]
    Morphine equivalents/patient/day 57.7 26.9 [11.6, 60.2] 46.5 17.2 [5.7, 45.5]
Pharmacologic Data:
    Patient gets only short acting opioids 60.2% 64.2%
    Patient gets ≥ 1 methadone/buprenorphine 13.7% 14.2%
Prescriptions, N (%) 977,245 (44.5%) 1,221,386 (55.5%)
    Morphine equivalents/prescription 1043 450 [150, 1000] 1555 675 [300, 1500]
    Short acting opioids (%) 86.1% 81.9%
    Methadone/buprenorphine (%) 4.3% 6.3%
    Top 3 medications (%) Hydrocodone/Acetaminophen (57.5%) Hydrocodone/Acetaminophen (55.8%)
Oxycodone/ Acetaminophen (10.5%) Oxycodone/ Acetaminophen (8.1%)
Morphine sulfate (5.4%) Morphine sulfate (6.4%)

* 3,571 patients doctor shopped continuously during their time in the data base.